CNBN Stock CNB Bank Shares (CNBN, $16.8) was a top loser this week, declining -5.08%

GET DAILY SIGNALS

Get AI intraday signals

CNBN - CNB Bank Shares, Inc.

Loading...

Price: $16.8

Daily change: -$0.3 (-1.75%)

Daily volume: 2K

Weekly price change: -$0.9 (-5.08%)

Capitalization: $90.8M

Industry: Regional Banks

CNB Bank Shares (CNBN, $16.8) was a top weekly loser, falling to $16.8 per share. Of the 872 stocks analyzed in the Regional Banks Industry throughout the week of April 4/2/2025 - 4/9/2025, 2025, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.

CNBN's RSI Oscillator is staying in overbought zone for 1 day

Watch for a price pull-back in the near future.

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

CNBN broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CNBN entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on CNBN as a result. In of 44 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNBN just turned positive on November 12, 2025. Looking at past instances where CNBN's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CNBN advanced for three days, in of 23 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.006) is normal, around the industry mean (1.113). P/E Ratio (9.651) is within average values for comparable stocks, (18.574). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.190). Dividend Yield (0.022) settles around the average of (0.036) among similar stocks. P/S Ratio (2.297) is also within normal values, averaging (5.167).